Michael Skynner compensation by year
BICYCLE THERAPEUTICS Summary Compensation Table · all 4 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2025 |
|---|---|---|---|---|
| Salary | $361,072 | $441,200 | $506,642 | $612,471 |
| Bonus | $0 | $0 | $21,735 | $0 |
| Stock awards | $0 | $0 | $0 | $490,000 |
| Option awards | $1,192,094 | $385,704 | $863,461 | $836,470 |
| Non-equity incentive | $212,390 | $280,112 | $341,990 | $319,355 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $52,572 | $47,695 | $54,929 | $68,714 |
| Total | $1,818,129 | $1,154,711 | $1,788,757 | $2,327,010 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BICYCLE THERAPEUTICS PLC DEF 14A filed April 22, 2026, accession 0001104659-26-046806, and prior-year filings.
How this page was built: the BICYCLE THERAPEUTICS PLC filed document, accession 0001104659-26-046806. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 35,000 | $247,800 | — |
| RSU | 15,750 | $111,510 | — |
| RSU | 5,469 | $38,721 | — |
| RSU | 938 | $6,641 | — |
| Option | 9,480 | — | $29.60 |
| Option | 87,000 | — | $14.00 |
| Option | 625 | — | $60.87 |
| Option | 29,167 | — | $18.08 |
Per the Outstanding Equity Awards at Fiscal Year-End table in BICYCLE THERAPEUTICS PLC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
5 Form 4 lines since the FY2025 proxy (filed April 22, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-05 | Sale | — | 503 | $3.57 | 154,726 |
| 2026-10-02 | Sale | — | 1,942 | $3.47 | 155,229 |
| 2026-07-15 | Grant or award derivative | — | 60,000 | $0.00 | 60,000 |
| 2026-07-06 | Sale | — | 532 | $4.31 | 157,171 |
| 2026-07-02 | Sale | — | 1,859 | $4.27 | 157,703 |
The 5 most recent of 5 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
BICYCLE THERAPEUTICS’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Kevin Lee | Chief Executive Officer | $6,341,473 |
| Michael Skynner · this page | Chief Technology Officer (2025); Chief Scientific Officer (effective January 1, 2026) | $2,327,010 |
| Alistair Milnes | Chief Operating Officer (2025); Chief Corporate Development Officer (effective March 17, 2026) | $2,292,424 |
Michael Skynner's compensation dossier, BICYCLE THERAPEUTICS
You have read Michael Skynner's totals and holdings. The dossier adds each equity grant BICYCLE THERAPEUTICS disclosed for Michael Skynner and BICYCLE THERAPEUTICS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full BICYCLE THERAPEUTICS compensation record
free company briefThis page is one person within BICYCLE THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the BICYCLE THERAPEUTICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BICYCLE THERAPEUTICS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BICYCLE THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.